Extended-release opioid agonists and antagonists represent an alternative treatment strategy for opioid use disorder. However their value is low for the money, according to this summary of an ICER analysis published in JMCP.
The benefits of extended release opioid agonists and antagonists in the highly personalized space of opioid use disorder treatment are described in this JMCP article by the CMO of Drug & Alcohol Treatment Centers, Pathway Healthcare.
Partnership Forum: Participants examined how to improve decision making for prior authorization and step therapy based on current market dynamics and considerations to ensure patients receive the most appropriate medications.
Learn different ways your AMCP Student Chapter can teach advocacy at your school, how you can support your State Advocacy Coordinator (S.A.C.) and even how to organize a Public Policy Symposium.
From AMCP's 2016 Student Chapter Leadership Academy: A case study from Rutgers University on how to successfully start an AMCP Chapter and a timeline for implementation and execution.